Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VORASIDENIB vs VUTRISIRAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

VORASIDENIB vs VUTRISIRAN: Safety Overview

Metric VORASIDENIB VUTRISIRAN
Total FAERS Reports 264 1,425
Deaths Reported 6 321
Death Rate 2.3% 22.5%
Hospitalizations 57 550
Average Patient Age 43.6 yrs 72.2 yrs
% Female Patients 11.1% 31.3%
FDA Approval Date Aug 6, 2024 Jun 13, 2022
Manufacturer Servier Pharmaceuticals LLC Alnylam Pharmaceuticals, Inc.
Route ORAL SUBCUTANEOUS
Marketing Status Prescription Prescription